Presented By
O’Reilly + Cloudera
Make Data Work
29 April–2 May 2019
London, UK
Volker Schnecke

Volker Schnecke
Big Data Analytic Specialist, Novo Nordisk

Website

Volker Schnecke has almost 20 years’ experience of working in research and development in the pharmaceutical industry. His current role is in late-stage clinical development at Novo Nordisk in Denmark, where he focuses on exploiting observational data to support the obesity pipeline. His tasks cover the whole drug discovery and development value chain, from collaborating with preclinical researchers to producing evidence for marketing of new medicines.

Sessions

15:30–16:00 Tuesday, 30 April 2019
Using electronic health records to predict health risks associated with obesity
Case studies
 Location: Capital Suite 12
Volker Schnecke (Novo Nordisk)
Average rating: ****.
(4.20, 5 ratings)
Today, more than 650 million people worldwide are obese, and most of them will develop additional health issues during their lifetime. However, not all are at equal risk. Volker Schnecke discusses how Novo Nordisk mines the electronic health records (EHRs) of millions of patients to understand the risk in people with obesity and to support the discovery of new medicines. Read more.